Mainstream

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Post ContentomerRead More

You might also be interested in reading SEO Builder Surpasses 2,000 Customers, Solidifies Position as a Trusted Leader in Citation Building.

May 16, 2025
In Mainstream